TP53 and breast cancer: In breast cancer, the over-representation of p53 loss-of-function mutations in the tumors with elevated hypoxia responses suggests that the loss of the p53's role in inhibiting HIF-1α protein stability and hypoxia-induced cell death [4],[55]–[57] may be a factor in these tumors.